When encountering patients with thrombocytosis (Sustained platelet count > 450x109/L), excluding secondary reasons such as post-splenectomy, malignancy, and connective tissue diseases, Type 2 and TPO mutation screenings should be performed if the patients have familial history. The gene discussed is TPO; the disease is connective tissue disorder.